91 related articles for article (PubMed ID: 25376447)
21. Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film.
Vicario-de-la-Torre M; Benítez-del-Castillo JM; Vico E; Guzmán M; de-Las-Heras B; Herrero-Vanrell R; Molina-Martínez IT
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7839-47. PubMed ID: 25377221
[TBL] [Abstract][Full Text] [Related]
22. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
Jee D; Park M; Lee HJ; Kim MS; Kim EC
J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027
[TBL] [Abstract][Full Text] [Related]
23. The Association between Dry Eye Disease and Physical Activity as well as Sedentary Behavior: Results from the Osaka Study.
Kawashima M; Uchino M; Yokoi N; Uchino Y; Dogru M; Komuro A; Sonomura Y; Kato H; Nishiwaki Y; Kinoshita S; Tsubota K
J Ophthalmol; 2014; 2014():943786. PubMed ID: 25485144
[TBL] [Abstract][Full Text] [Related]
24. Effects of Systane(®) Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye.
Aguilar AJ; Marquez MI; Albera PA; Tredicce JL; Berra A
Clin Ophthalmol; 2014; 8():2365-72. PubMed ID: 25473263
[TBL] [Abstract][Full Text] [Related]
25. Ophthalmological features of Parkinson disease.
Nowacka B; Lubinski W; Honczarenko K; Potemkowski A; Safranow K
Med Sci Monit; 2014 Nov; 20():2243-9. PubMed ID: 25387009
[TBL] [Abstract][Full Text] [Related]
26. Weak gelation of hydrophobic guar by albumin in simulated human tear solutions.
Mafi R; Pelton R; Cui Y; Ketelson H
Biomacromolecules; 2014 Dec; 15(12):4637-42. PubMed ID: 25380278
[TBL] [Abstract][Full Text] [Related]
27. A thermo-responsive protein treatment for dry eyes.
Wang W; Jashnani A; Aluri SR; Gustafson JA; Hsueh PY; Yarber F; McKown RL; Laurie GW; Hamm-Alvarez SF; MacKay JA
J Control Release; 2015 Feb; 199():156-67. PubMed ID: 25481446
[TBL] [Abstract][Full Text] [Related]
28. Prominent Decrease of Tear Meniscus Height With Contact Lens Wear and Efficacy of Eye Drop Instillation.
Nagahara Y; Koh S; Maeda N; Nishida K; Watanabe H
Eye Contact Lens; 2015 Sep; 41(5):318-22. PubMed ID: 25839348
[TBL] [Abstract][Full Text] [Related]
29. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye.
Lin BW; Chen MZ; Fan SX; Chuck RS; Zhou SY
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):45-53. PubMed ID: 25491293
[TBL] [Abstract][Full Text] [Related]
30. The association between dry eye disease and depression and anxiety in a large population-based study.
van der Vaart R; Weaver MA; Lefebvre C; Davis RM
Am J Ophthalmol; 2015 Mar; 159(3):470-4. PubMed ID: 25461298
[TBL] [Abstract][Full Text] [Related]
31. Signs and Symptoms of Dry Eye in Keratoconus Patients: A Pilot Study.
Carracedo G; Recchioni A; Alejandre-Alba N; Martin-Gil A; Crooke A; Morote IJ; Pintor J
Curr Eye Res; 2015; 40(11):1088-94. PubMed ID: 25495191
[TBL] [Abstract][Full Text] [Related]
32. Automatic assessment of tear film break-up dynamics.
Ramos L; Barreira N; Pena-Verdeal H; Giráldez MJ
Stud Health Technol Inform; 2014; 207():173-82. PubMed ID: 25488223
[TBL] [Abstract][Full Text] [Related]
33. Tear condition following unilateral ptosis surgery.
Bagheri A; Najmi H; Salim RE; Yazdani S
Orbit; 2015 Apr; 34(2):66-71. PubMed ID: 25474275
[TBL] [Abstract][Full Text] [Related]
34. Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus LASIK.
Denoyer A; Landman E; Trinh L; Faure JF; Auclin F; Baudouin C
Ophthalmology; 2015 Apr; 122(4):669-76. PubMed ID: 25458707
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of and risk factors for dry eye symptom in mainland china: a systematic review and meta-analysis.
Liu NN; Liu L; Li J; Sun YZ
J Ophthalmol; 2014; 2014():748654. PubMed ID: 25386359
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study.
Ohashi Y; Munesue M; Shimazaki J; Takamura E; Yokoi N; Watanabe H; Nomura A; Shimada F
Adv Ther; 2020 Feb; 37(2):707-717. PubMed ID: 31834617
[TBL] [Abstract][Full Text] [Related]
37. A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery.
Kim S; Shin J; Lee JE
Sci Rep; 2021 Apr; 11(1):9124. PubMed ID: 33907267
[TBL] [Abstract][Full Text] [Related]
38. Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome.
Kang DH; Lee YW; Hwang KY; Koh KM; Kwon YA; Kim BY; Song SW; Kim KY
Int J Ophthalmol; 2019; 12(10):1555-1560. PubMed ID: 31637190
[TBL] [Abstract][Full Text] [Related]
39. Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial.
Jun I; Choi S; Lee GY; Choi YJ; Lee HK; Kim EK; Seo KY; Kim TI
Sci Rep; 2019 Sep; 9(1):12659. PubMed ID: 31477748
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials.
Zhao X; Xia S; Chen Y
Medicine (Baltimore); 2017 Sep; 96(39):e8174. PubMed ID: 28953672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
